FT NASAL DECONGEST ER 120 MG

Pseudoephedrine hydrochloride
$0.2853per EA
OTC

Strength

120 mg/1

NDC

70677101901

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA077442

On Market Since

8/10/2023

Pharmacological Classes

Adrenergic alpha-Agonists
alpha-Adrenergic Agonist

Price History

1W

0.0%

1M

+1.6%

3M

+5.5%

6M

+7.1%

1Y

+5.7%

3Y

N/A

5Y

N/A

All

+3.7%